跳至主要内容
临床试验/CTRI/2023/02/049730
CTRI/2023/02/049730尚未招募未知

Efficacy and safety of Fixed dose combinations of newer SGLT2 and DPP-IV inhibitors versus therapy with each mono-component, in poorly controlled type 2 diabetes on Metformin: A Randomized open-label trial

Jawaharlal Nehru Medical college, Aligarh Muslim University0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age >= 18 years
  • Diagnosis of type 2 diabetes
  • On metformin dose (>=1000 mg/d)
  • HbA1c >=8 to 10.0%
  • Fasting plasma glucose (FPG) <=15 mmol/L (<=270 mg/dl)
  • Exclusion criteria

排除标准

  • Type 1 diabetic patient and patient on Insulin
  • Pregnancy, diabetic ketoacidosis
  • A cardiovascular event in the 3 months before enrolment.
  • Moderate or severe impairment of renal function (estimated glomerular filtration rate (eGFR) of <60 mL/min/1.73 m2)

研究者

发起方
Jawaharlal Nehru Medical college, Aligarh Muslim University

相似试验